Article Details

Acquisition of TeneoTwo and its clinical-stage T-cell engager completed - Labiotech.eu

Retrieved on: 2022-08-11 11:37:58

Tags for this article:

Click the tags to see associated articles and topics

Acquisition of TeneoTwo and its clinical-stage T-cell engager completed - Labiotech.eu. View article details on hiswai:

Excerpt

AstraZeneca has said today (August 11) that it has completed its purchase of TeneoTwo including its B-cell non-Hodgkin lymphoma drug.

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up